Oct 15 (Reuters) - UK's MHRA:
* UK'S MHRA: ELAFIBRANOR APPROVED TO TREAT ADULTS WITH A
RARE
LIVER DISEASE KNOWN AS PRIMARY BILIARY CHOLANGITIS
Further company coverage: